Pharmaceuticals & Biotechnology • Mid Cap
Biocon Ltd.
Performance
Stories & Reports






Announcements
Biocon Limited has informed the Exchange regarding a press release dated November 18, 2026, titled "Biocon s Pertuzumab Gets Marketing Authorization in EU, First Biosimilar Approved Under New Tailored Clinical Approach".
View Full DocBiocon Ltd. Share Price
As of 23 November 2026, Biocon Ltd. share price is ₹364.40. The stock opened at ₹362.90, compared to its previous close of ₹363.65. During today's trading session, Biocon Ltd. share price moved in the range of ₹360.90 to ₹365.70.
Looking at its last 52-week performance, the stock has touched a low of ₹318.40 and a high of ₹447.15. On the performance front, Biocon Ltd. share price is down 7.78% on a year-on-year basis.
The market capitalization of Biocon Ltd. is ₹49908.85 Cr, with a P/E ratio of 37.70.
Moving Averages




